SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-121451
Filing Date
2022-04-27
Accepted
2022-04-27 06:12:01
Documents
5
Period of Report
2022-06-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A d345768ddef14a.htm DEF 14A 631502
2 GRAPHIC g345768g01p01.jpg GRAPHIC 422384
3 GRAPHIC g345768g02p02.jpg GRAPHIC 302557
4 GRAPHIC g345768g28m20.jpg GRAPHIC 85278
5 GRAPHIC g345768g86t40.jpg GRAPHIC 19686
  Complete submission text file 0001193125-22-121451.txt   1776044
Mailing Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121
Business Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35670 | Film No.: 22856169
SIC: 2834 Pharmaceutical Preparations